Skip to main content
    N

    National Health Investors Inc (NHI)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $60.68
    -2.27 (-3.61%)

    Market Cap: $3.09B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    National Health Investors Inc (NHI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    National Health Investors reported revenue of $375.63M for the fiscal year ended Dec 31, 2025, up 12.1% from the year before. That year, net income was $140.79M with a net margin of 37.5%, operating cash flow was $236.56M and free cash flow was -$37.51M. The quarter ended Sep 30, 2026 had revenue of $113.48M and net income of $563.21M.

    Revenue and Margins

    The operating margin was 51.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $248.46M, a compound annual rate of 4.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$375.63M+12.1%100.0%51.7%37.5%
    Dec 2024$335.18M+4.8%100.0%54.7%40.8%
    Dec 2023$319.83M+4.3%100.0%55.4%42.0%
    Dec 2022$306.54M+2.6%100.0%21.1%21.4%
    Dec 2021$298.71M-10.2%100.0%27.6%37.5%
    Dec 2020$332.81M+4.6%100.0%51.4%55.7%
    Dec 2019$318.08M+8.0%100.0%50.7%50.4%
    Dec 2018$294.61M+5.7%100.0%52.6%52.4%
    Dec 2017$278.66M+12.2%100.0%54.4%57.2%
    Dec 2016$248.46MN/A100.0%47.8%61.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 3.0% from the year before. In the quarter ended Sep 2026, net income rose 1634.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$375.63M$335.18M$319.83M$306.54M$298.71M$332.81M$318.08M$294.61M$278.66M$248.46M
    Gross profit$375.63M$335.18M$319.83M$306.54M$298.71M$332.81M$318.08M$294.61M$278.66M$248.46M
    Operating income$194.03M$183.20M$177.12M$64.68M$82.58M$171.04M$161.27M$155.07M$151.49M$118.77M
    Net income$140.79M$136.64M$134.38M$65.50M$111.97M$185.31M$160.45M$154.33M$159.37M$152.72M
    EBITDA$280.84M$274.14M$266.79M$147.64M$200.52M$280.04M$242.71M$230.58M$234.14M$217.11M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$113.48M$121.32M$115.13M$105.71M$89.85M$90.66M$89.30M$84.24M$82.94M$86.49M$81.51M$79.47M
    Gross profit$113.48M$121.32M$115.13M$105.71M$89.85M$90.66M$89.30M$84.24M$82.94M$86.49M$81.51M$79.47M
    Operating income$29.77M$49.79M$52.15M$78.97M$46.06M$35.05M$47.63M$74.97M$28.24M$34.72M$45.27M$58.82M
    Net income$563.21M$55.36M$39.75M$37.80M$32.48M$36.69M$33.82M$42.79M$28.24M$34.95M$30.66M$31.72M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.29B exceeded cash and equivalents by $1.27B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$2.80B$2.61B$2.49B$2.51B$2.84B$3.12B$3.04B$2.75B$2.55B$2.40B
    Current assets$19.62M$24.29M$22.35M$19.29M$37.41M$43.34M$5.21M$4.66M$3.06M$4.64M
    Cash and equivalents$19.62M$24.29M$22.35M$19.29M$37.41M$43.34M$5.21M$4.66M$3.06M$4.64M
    Total liabilities$1.26B$1.23B$1.21B$1.22B$1.32B$1.60B$1.54B$1.36B$1.22B$1.19B
    Short-term debt$125.00M$331.20M$245.00M$415.41M$75.39M$458.37M$1.23M$22.81M$21.27M$15.86M
    Long-term debt$1.16B$1.15B$1.14B$1.15B$1.24B$1.50B$1.44B$1.28B$1.15B$1.12B
    Shareholder equity$1.52B$1.37B$1.25B$1.27B$1.51B$1.51B$1.50B$1.39B$1.32B$1.21B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$3.24B$2.96B$2.89B$2.80B$2.69B$2.70B$2.78B$2.61B$2.46B$2.48B$2.48B$2.49B
    Total liabilities$1.14B$1.37B$1.36B$1.26B$1.19B$1.20B$1.34B$1.23B$1.21B$1.21B$1.21B$1.21B
    Cash and equivalents$46.56M$30.39M$24.95M$19.62M$81.63M$18.64M$135.00M$24.29M$15.55M$14.77M$11.36M$22.35M
    Shareholder equity$2.09B$1.57B$1.51B$1.52B$1.48B$1.48B$1.43B$1.37B$1.23B$1.24B$1.25B$1.25B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$236.56M$207.77M$184.45M$185.34M$210.86M$232.15M$240.96M$207.87M$198.09M$176.64M
    Capital expenditures$274.07M$138.13M$38.08M$6.36M$46.82M$102.71M$219.19M$131.76M$175.79M$362.63M
    Free cash flow-$37.51M$69.64M$146.37M$178.98M$164.04M$129.44M$21.77M$76.11M$22.30M-$186.00M
    Dividends paid$170.61M$157.66M$157.52M$162.69M$183.81M$195.33M$179.75M$165.39M$153.04M$139.87M
    Share repurchases$767.00K$930.00K$0$152.02M$0$0N/AN/AN/AN/A
    Investing cash flow-$269.15M-$192.31M-$11.63M$197.94M$185.28M-$89.71M-$342.52M-$250.29M-$163.85M-$329.84M
    Financing cash flow$25.71M-$13.57M-$169.72M-$401.25M-$402.99M-$111.76M$107.32M$44.26M-$35.05M$144.16M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$47.98M$64.97M$53.44M$67.74M$62.53M$59.82M$46.48M$57.57M$48.63M$60.74M$40.83M$53.20M
    Capital expenditures$18.03M$124.40M$105.49M$143.08M$9.85M$56.50M$74.48M$128.26M$4.68M$6.89M$2.98M$1.16M
    Free cash flow$29.95M-$59.42M-$52.05M-$75.35M$52.68M$3.32M-$28.01M-$70.69M$43.95M$53.85M$37.85M$52.04M
    Last 12 quarters

    Frequently Asked Questions About NHI

    What is National Health Investors' annual revenue?

    National Health Investors reported revenue of $375.63M for the fiscal year ended Dec 31, 2025.

    How fast is National Health Investors' revenue growing?

    Revenue was up 12.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 7.0%.

    Is National Health Investors profitable?

    Yes. National Health Investors reported net income of $140.79M for the fiscal year ended Dec 31, 2025, with a net margin of 37.5%.

    How much free cash flow does NHI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $236.56M minus capital expenditures of $274.07M produced free cash flow of -$37.51M.

    How much debt does National Health Investors have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.16B, short-term debt of $125.00M and cash and equivalents of $19.62M.